Literature DB >> 29658189

Side Effects of Long-Term Proton Pump Inhibitor Use: A Review.

Peter Fentz Haastrup1, Wade Thompson1, Jens Søndergaard1, Dorte Ejg Jarbøl1.   

Abstract

Proton pump inhibitors (PPIs) are widely used, and concerns about overuse have been raised. Therefore, side effects are important to be aware of and several suggested side effects of long-term use have been studied. In this MiniReview, we sum up the evidence of side effects related to long-term PPI treatment. Suspected side effects are mainly related to increased susceptibility to infections, secondary hypergastrinaemia, impeded absorption of micronutrients or idiosyncratic reactions. Most of the potential side effects have only been evaluated in observational studies demonstrating conflicting and weak associations with a substantial risk of confounding. However, a high probability of causality seems to be established for the side effects increased risk of gastrointestinal infections and rebound acid hypersecretion following discontinuation of treatment due to secondary hypergastrinaemia. The risk of side effects should not be a reason to withhold PPIs from patients with a true indication, and worry about poorly proven side effects should not lead to unnecessary discontinuation. The most important safety issue regarding PPI therapy is to critically evaluate the indication when initiating treatment and reconsidering the indication in long-term-treated patients.
© 2018 Nordic Association for the Publication of BCPT (former Nordic Pharmacological Society).

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29658189     DOI: 10.1111/bcpt.13023

Source DB:  PubMed          Journal:  Basic Clin Pharmacol Toxicol        ISSN: 1742-7835            Impact factor:   4.080


  20 in total

1.  Use and prescription appropriateness of drugs for peptic ulcer and gastrooesophageal reflux disease in hospitalized older people.

Authors:  C Franchi; P M Mannucci; A Nobili; I Ardoino
Journal:  Eur J Clin Pharmacol       Date:  2019-12-18       Impact factor: 2.953

2.  People exposed to proton-pump inhibitors shortly preceding COVID-19 diagnosis are not at an increased risk of subsequent hospitalizations and mortality: A nationwide matched cohort study.

Authors:  Ivan Kodvanj; Jan Homolak; Vladimir Trkulja
Journal:  Br J Clin Pharmacol       Date:  2022-09-12       Impact factor: 3.716

3.  Use of Proton Pump Inhibitors in Hungary: Mixed-Method Study to Reveal Scale and Characteristics.

Authors:  Mária Matuz; Ria Benkő; Zsófia Engi; Krisztina Schváb; Péter Doró; Réka Viola; Mária Szabó; Gyöngyvér Soós
Journal:  Front Pharmacol       Date:  2020-09-08       Impact factor: 5.810

4.  Evaluation of mutagenesis, necrosis and apoptosis induced by omeprazole in stomach cells of patients with gastritis.

Authors:  Ana Maria Oliveira Ferreira da Mata; Marcia Fernanda Correia Jardim Paz; Ag-Anne Pereira Melo de Menezes; Antonielly Campinho Dos Reis; Bruna da Silva Souza; Carlos Dimas de Carvalho Sousa; Sônia Alves Machado; Thiago Soares Gondim Medeiros; Chandan Sarkar; Muhammad Torequl Islam; Javad Sharifi-Rad; Sevgi Durna Daştan; Mohammed M Alshehri; João Marcelo de Castro E Sousa; Ana Amélia de Carvalho Melo Cavalcante
Journal:  Cancer Cell Int       Date:  2022-04-18       Impact factor: 6.429

5.  Burden of drug use for gastrointestinal symptoms and functional gastrointestinal disorders in France: a national study using reimbursement data for 57 million inhabitants.

Authors:  Philippe Tuppin; Sébastien Rivière; David Deutsch; Christelle Gastaldi-Menager; Jean-Marc Sabaté
Journal:  Therap Adv Gastroenterol       Date:  2019-07-12       Impact factor: 4.409

6.  A retrospective study on the evaluation of the symptoms, medications and improvement of the quality of life of patients undergoing robotic surgery for gastroesophageal reflux disease.

Authors:  Sofia K Konstantinidou; Penelope Kostaras; Georgios-Eleftherios Anagnostopoulos; Sophia-Liberty Markantonis; Vangelis Karalis; Konstantinos Konstantinidis
Journal:  Exp Ther Med       Date:  2020-12-27       Impact factor: 2.447

7.  Proton pump inhibitors associated acute kidney injury and chronic kidney disease: data mining of US FDA adverse event reporting system.

Authors:  Bin Wu; Dan Li; Ting Xu; Min Luo; Zhiyao He; Yuwen Li
Journal:  Sci Rep       Date:  2021-02-11       Impact factor: 4.379

8.  A Randomized Open-Label Study of Two Methods of Proton Pump Inhibitors Discontinuation.

Authors:  Emily Hendricks; Aman N Ajmeri; Monider M Singh; Milliejoan Mongalo; Lynne J Goebel
Journal:  Cureus       Date:  2021-05-14

9.  ACVIM consensus statement: Support for rational administration of gastrointestinal protectants to dogs and cats.

Authors:  Stanley L Marks; Peter H Kook; Mark G Papich; M K Tolbert; Michael D Willard
Journal:  J Vet Intern Med       Date:  2018-10-31       Impact factor: 3.333

Review 10.  Insights into Effects/Risks of Chronic Hypergastrinemia and Lifelong PPI Treatment in Man Based on Studies of Patients with Zollinger-Ellison Syndrome.

Authors:  Lingaku Lee; Irene Ramos-Alvarez; Tetsuhide Ito; Robert T Jensen
Journal:  Int J Mol Sci       Date:  2019-10-16       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.